MergerLinks Header Logo

Announced

Laboratorios Sanfer to acquire Vitalis from ACON Investments.

Synopsis

Laboratorios Sanfer, a pharmaceutical company, agreed to acquire Vitalis, a manufacturer and wholesaler of injectable products used in hospitals, medical institutions and pharmacies, from ACON Investments, a private equity firm. Financial terms were not disclosed. "The team at Vitalis is enthusiastic to begin this new era of growth, consolidating its position as a key player in the Latin American pharmaceutical market. We are confident that Sanfer's experience, know-how and leadership will exponentially boost the company's growth and expansion plans," Alberto Hernandez, ACON Partner.

Principals

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US